NASA Search For Extraterrestrials Faces Uncertain Funding Future

It sits nestled in the National Aeronautics and Space Administration budget, drawing a scant one-tenth of 1 percent of the $15 billion total, yet the Search for Extraterrestrial Intelligence (SETI) is singled out on an almost annual basis for congressional flagellation. And this year is no exception--even as NASA gears up for the October inception of a 10-year effort to tune in radio signals from advanced alien civilizations. The problem for SETI, congressional staffers say, is the "giggle fa

Written byScott Veggeberg
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The problem for SETI, congressional staffers say, is the "giggle factor." They say it's easy for representatives to get their names in print by taking cheap shots at the program, linking it with a search for little green men and flying saucers.

In fact, that was exactly the approach used by Rep. John Duncan (R-Tenn.) when he successfully engineered the elimination of funding for SETI, via a recently passed House authorization bill for fiscal year 1993. "This is a program that the Associated Press described as a search for space aliens," Duncan told the House on April 29. "With our nation in such financial straits as at present, I find it incredible that we are continuing on with this program, this ridiculous luxury."

Apparently, many members of Congress agreed with Duncan's assessment of SETI and voted in favor of his amendment to zero out the proposed $13.5 million in FY ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies